Sagar Jayantilal Dholariya (Sagar Dholariya)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Glycemic Control

Polycystic Ovary Syndrome

Ejection Fraction

Peritoneal Dialysis

Top Venues

Indian journal of clinical biochemistry : IJCB

Expert review of clinical pharmacology

Journal of laboratory physicians

Expert opinion on pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Sagar Jayantilal Dholariya, Siddhartha Dutta, Ragini Singh, Deepak N Parchwani, Amit Sonagra, Mehul Kaliya
Bexagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, for improvement of glycemia in type 2 diabetes mellitus: a systematic review and meta-analysis. Expert opinion on pharmacotherapy (2023)
Sagar Jayantilal Dholariya, Deepak N Parchwani, Siddhartha Dutta, Ragini Singh
Clinical efficacy and safety of dasiglucagon in severe hypoglycemia associated with patients of type 1 diabetes mellitus: a systematic review and meta-analysis. Expert review of clinical pharmacology (2022)
Deepak Parchwani, Sagar Jayantilal Dholariya, Sohil Takodara, Ragini Singh, Vivek Kumar Sharma, Alpana Saxena, Digishaben D Patel, Madhuri Radadiya
Analysis of Prediagnostic Circulating Levels of Gonadotropins and Androgens with Risk of Epithelial Ovarian Cancer. Journal of laboratory physicians 14 (1) (2022)
Rohit Kumar Gupta, Sagar Jayantilal Dholariya, Smita Kaushik, S K Gupta, Reva Tripathi, Shyam Lata Jain
Hyperinsulinemia and Hypoadiponectinemia are Associated with Increased Risk for Occurrence of Ovarian Cancer in Non-diabetic Women of North Indian Population. Indian journal of clinical biochemistry : IJCB 36 (2) (2020)